Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03665922 · ClinicalTrials.gov registry record · NA
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT03665922 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 39 participants.
The verdict
NCT03665922, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This study will test whether oral intake of a dietary supplement called BroccoMax®, which is a special blend of broccoli extract containing a chemical called sulforaphane (hereafter abbreviated as SFN), may result in changes in chemicals that feed prostate cancer. BroccoMax® is available over the counter.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT BroccoMax®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03665922
The ClinicalTrials.gov registry entry for NCT03665922 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03665922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03665922 about?
NCT03665922 is a clinical study titled "Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer". This study will test whether oral intake of a dietary supplement called BroccoMax®, which is a special blend of broccoli extract containing a chemical called sulforaphane (hereafter abbreviated as SFN), may result in changes in chemicals that feed prostate cancer. BroccoMax® is available over the co...
What is the current status of trial NCT03665922?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2019-05-01. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03665922?
The interventions under investigation include: Placebo (OTHER), BroccoMax® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03665922?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.